For PV diagnosis, most HCPs reported using serum erythropoietin (EPO) level (44/57, 77%), alongside an FBC (49/57, 86%) and peripheral blood JAK2 V617F mutational analysis (49/57, 86%). The gene discussed is EPO; the disease is acquired polycythemia vera.